Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Fibrocell Science Inc. (FCSC)

1.97   -0.05 (-2.48%) 06-20 16:00
Open: 2.01 Pre. Close: 2.02
High: 2.03 Low: 1.9625
Volume: 31,304 Market Cap: 19M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.035 - 2.045 2.045 - 2.053
Low: 1.933 - 1.946 1.946 - 1.957
Close: 1.951 - 1.972 1.972 - 1.988

Technical analysis

as of: 2019-06-20 4:36:37 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.58     One year: 3.01
Support: Support1: 1.91    Support2: 1.72
Resistance: Resistance1: 2.21    Resistance2: 2.58
Pivot: 1.94
Moving Average: MA(5): 1.99     MA(20): 1.94
MA(100): 2.05     MA(250): 2.07
MACD: MACD(12,26): -0.02     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 56.75     %D(3): 50.35
RSI: RSI(14): 48.76
52-week: High: 3.36  Low: 1.45  Change(%): -40.5
Average Vol(K): 3-Month: 84962  10-Days: 5217

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
FCSC has closed below upper band by 36.5%. Bollinger Bands are 62.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to FCSC's normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 13 Jun 2019 16:17:00 Z
Savara Plunges on Failure of Late-Stage Study on Molgradex

Thu, 30 May 2019 15:23:26 Z
Fibrocell Up on FDA Designation for Gene Therapy Candidate

Wed, 29 May 2019 15:14:46 Z
Is Fibrocell Science (FCSC) Stock Outpacing Its Medical Peers This Year?

Wed, 29 May 2019 14:07:32 Z
Health Care Sector Update for 05/29/2019: SOLY, CARA, FCSC, JNJ, PFE, ABT, MRK, AMGN

Thu, 16 May 2019 16:17:31 Z
The Zacks Analyst Blog Highlights: Limbach, Health Insurance, Fibrocell, Camden and First Business

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 9.76
Shares Float (M) 6.10
% Held by Insiders
% Held by Institutions 32.30
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.460
EPS Est. Current Year -2.170
EPS Est. Next Year -1.060
EPS Est. Next Quarter -0.350
Forward EPS -0.629
Book Value (p.s.) 3.040
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -76.8
Return on Equity (ttm) -203.6
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -11.03
Levered Free Cash Flow (M) -7.32

Stock Valuations

P/E -1.35
P/E Growth Ratio -0.02
P/BV 0.65
P/CF -1.74

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-05-25
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.